Trials / Conditions / Previously Treated Childhood Rhabdomyosarcoma

Previously Treated Childhood Rhabdomyosarcoma

21 registered clinical trials studyying Previously Treated Childhood Rhabdomyosarcoma.

Status	Trial	Sponsor	Phase
Withdrawn	Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors NCT02011126	Children's Oncology Group	Phase 2
Completed	Biomarkers in Patients With Advanced Rhabdomyosarcoma NCT01668095	Children's Oncology Group	—
Completed	Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma NCT01614795	National Cancer Institute (NCI)	Phase 2
Completed	Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma NCT01626170	Children's Oncology Group	—
Completed	Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma NCT01609803	Children's Oncology Group	—
Completed	Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liv NCT01502410	National Cancer Institute (NCI)	Phase 2
Completed	Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or NCT01305200	Children's Oncology Group	Phase 3
Completed	Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia NCT01154816	Children's Oncology Group	Phase 2
Completed	Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases NCT01586104	Ann & Robert H Lurie Children's Hospital of Chicago	N/A
Completed	Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients NCT01222715	National Cancer Institute (NCI)	Phase 2
Completed	Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors NCT00831844	National Cancer Institute (NCI)	Phase 2
Completed	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta NCT00720174	National Cancer Institute (NCI)	Phase 1
Completed	Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of T NCT00070109	Children's Oncology Group	Phase 2
Completed	Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem NCT00408681	Fred Hutchinson Cancer Center	N/A
Completed	Ixabepilone in Treating Young Patients With Refractory Solid Tumors NCT00331643	National Cancer Institute (NCI)	Phase 2
Completed	Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Tr NCT00309907	Children's Oncology Group	Phase 2
Completed	Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors NCT00093821	National Cancer Institute (NCI)	Phase 1
Completed	Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors NCT00077454	National Cancer Institute (NCI)	Phase 1
Completed	Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma NCT00025363	National Cancer Institute (NCI)	Phase 2
Completed	Irinotecan in Treating Children With Refractory Solid Tumors NCT00004078	Children's Oncology Group	Phase 2
Completed	Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Sof NCT00919269	Children's Oncology Group	—